The positive associations that were present in both control and cancer samples included relationships between FABP4 and CD36/SR-B2 (control: p = 0.008, r = 0.692; cancer: p = 0.0003, r = 0.647), FATP4 and LAT1 (control: p = 0.037, r = 0.569; cancer: p = 0.012, r = 0.478), FATP4 and ASCT2 (control: p = 0.0001, r = 0.868; cancer: p = 0.03, r = 0.418), MCT1 and ASCT2 (control: p = 0.0003, r = 0.903; cancer: p = 0.01, r = 0.488) as well as MCT4 and LAT1 (control: p = 0.027, r = 0.596; cancer: p = 0.044, r = 0.398) (Figure 3). This evidence concerns the gene MED20 and cancer.